Aggressive form of leukemia ‘wiped out’ by genetically modified immune cell therapy
Over the past five years, scientists have become good at taking out patients’ immune cells and tweaking them into a genetically modified drug that can hunt down cancer.
Chronic lymphocytic leukaemia (CLL) is the most common kind of the blood cancer in adults, killing 1,000 people a year in Britain.
“Cure is a difficult word,” Dr. Gill said. “They’re not cured — we will know they are cured if they remain cancer-free for a long time. But the majority of patients have no detectable CLL left.”